153 related articles for article (PubMed ID: 11196452)
21. Persistent testicular delta5-isomerase-3beta-hydroxysteroid dehydrogenase (delta5-3beta-HSD) deficiency in the delta5-3beta-HSD form of congenital adrenal hyperplasia.
Schneider G; Genel M; Bongiovanni AM; Goldman AS; Rosenfield RL
J Clin Invest; 1975 Apr; 55(4):681-90. PubMed ID: 164481
[TBL] [Abstract][Full Text] [Related]
22. Mutations in the type II 3 beta-hydroxysteroid dehydrogenase gene in a patient with classic salt-wasting 3 beta-hydroxysteroid dehydrogenase deficiency congenital adrenal hyperplasia.
Chang YT; Kappy MS; Iwamoto K; Wang J; Yang X; Pang S
Pediatr Res; 1993 Nov; 34(5):698-700. PubMed ID: 8284113
[TBL] [Abstract][Full Text] [Related]
23. Structure, function and tissue-specific gene expression of 3β-hydroxysteroid dehydrogenase/5-ene-4-ene isomerase enzymes in classical and peripheral intracrine steroidogenic tissues.
Labrie F; Simard J; Luu-The V; Bélanger A; Pelletier G
J Steroid Biochem Mol Biol; 1992 Dec; 43(8):805-26. PubMed ID: 22217825
[TBL] [Abstract][Full Text] [Related]
24. A novel missense mutation in the HSD3B2 gene, underlying nonsalt-wasting congenital adrenal hyperplasia. new insight into the structure-function relationships of 3β-hydroxysteroid dehidrogenase type II.
Baquedano MS; Ciaccio M; Marino R; Perez Garrido N; Ramirez P; Maceiras M; Turjanski A; Defelipe LA; Rivarola MA; Belgorosky A
J Clin Endocrinol Metab; 2015 Jan; 100(1):E191-6. PubMed ID: 25322271
[TBL] [Abstract][Full Text] [Related]
25. Two novel HSD3B2 missense mutations with diverse residual enzymatic activities for Δ5-steroids.
Takasawa K; Ono M; Hijikata A; Matsubara Y; Katsumata N; Takagi M; Morio T; Ohara O; Kashimada K; Mizutani S
Clin Endocrinol (Oxf); 2014 Jun; 80(6):782-9. PubMed ID: 24372086
[TBL] [Abstract][Full Text] [Related]
26. Congenital adrenal hyperplasia caused by a novel homozygous frameshift mutation 273 delta AA in type II 3 beta-hydroxysteroid dehydrogenase gene (HSD3B2) in three male patients of Afghan/Pakistani origin.
Simard J; Rhéaume E; Leblanc JF; Wallis SC; Joplin GF; Gilbey S; Allanson J; Mettler G; Bettendorf M; Heinrich U
Hum Mol Genet; 1994 Feb; 3(2):327-30. PubMed ID: 8004103
[TBL] [Abstract][Full Text] [Related]
27. Structure-function relationships and molecular genetics of the 3 beta-hydroxysteroid dehydrogenase gene family.
Simard J; Sanchez R; Durocher F; Rhéaume E; Turgeon C; Labrie Y; Luu-The V; Mebarki F; Morel Y; de Launoit Y
J Steroid Biochem Mol Biol; 1995 Dec; 55(5-6):489-505. PubMed ID: 8547174
[TBL] [Abstract][Full Text] [Related]
28. Congenital adrenal hyperplasia due to point mutations in the type II 3 beta-hydroxysteroid dehydrogenase gene.
Rhéaume E; Simard J; Morel Y; Mebarki F; Zachmann M; Forest MG; New MI; Labrie F
Nat Genet; 1992 Jul; 1(4):239-45. PubMed ID: 1363812
[TBL] [Abstract][Full Text] [Related]
29. 3β-Hydroxysteroid Dehydrogenase Type 2 (3βHSD2) Deficiency due to a Novel Compound Heterozygosity of a Missense Mutation (p.Thr259Met) and Frameshift Deletion (p.Lys273ArgFs*7) in an Undervirilized Infant Male with Salt Wasting.
Leka-Emiri S; Taibi L; Mavroeidi V; Vlachopapadopoulou EA; Kafetzi M; Michalacos S; de Roux N
Sex Dev; 2022; 16(1):64-69. PubMed ID: 34628416
[TBL] [Abstract][Full Text] [Related]
30. Congenital adrenal hyperplasia owing to 3 beta-hydroxysteroid dehydrogenase deficiency.
Pang S
Endocrinol Metab Clin North Am; 2001 Mar; 30(1):81-99, vi-vii. PubMed ID: 11344940
[TBL] [Abstract][Full Text] [Related]
31. Characterization of two novel homozygous missense mutations involving codon 6 and 259 of type II 3beta-hydroxysteroid dehydrogenase (3betaHSD) gene causing, respectively, nonsalt-wasting and salt-wasting 3betaHSD deficiency disorder.
Zhang L; Mason JI; Naiki Y; Copeland KC; Castro-Magana M; Gordon-Walker TT; Chang YT; Pang S
J Clin Endocrinol Metab; 2000 Apr; 85(4):1678-85. PubMed ID: 10770215
[TBL] [Abstract][Full Text] [Related]
32. Mutations in the type II 3beta-hydroxysteroid dehydrogenase (HSD3B2) gene can cause premature pubarche in girls.
Marui S; Castro M; Latronico AC; Elias LL; Arnhold IJ; Moreira AC; Mendonca BB
Clin Endocrinol (Oxf); 2000 Jan; 52(1):67-75. PubMed ID: 10651755
[TBL] [Abstract][Full Text] [Related]
33. Phenotypic variability and origins of mutations in the gene encoding 3beta-hydroxysteroid dehydrogenase type II.
McCartin S; Russell AJ; Fisher RA; Wallace AM; Arnhold IJ; Mason JI; Varley J; Mendonca BB; Sutcliffe RG
J Mol Endocrinol; 2000 Feb; 24(1):75-82. PubMed ID: 10656999
[TBL] [Abstract][Full Text] [Related]
34. The molecular and clinical spectrum of 3beta-hydroxysteroid dehydrogenase deficiency disorder.
Pang S
Trends Endocrinol Metab; 1998 Feb; 9(2):82-6. PubMed ID: 18406247
[TBL] [Abstract][Full Text] [Related]
35. Clinical perspectives in congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase type 2 deficiency.
Al Alawi AM; Nordenström A; Falhammar H
Endocrine; 2019 Mar; 63(3):407-421. PubMed ID: 30719691
[TBL] [Abstract][Full Text] [Related]
36. A case of 3beta-hydroxysteroid dehydrogenase type II (HSD3B2) deficiency picked up by neonatal screening for 21-hydroxylase deficiency: difficulties and delay in etiologic diagnosis.
Nordenström A; Forest MG; Wedell A
Horm Res; 2007; 68(4):204-8. PubMed ID: 17496421
[TBL] [Abstract][Full Text] [Related]
37. Late diagnosis of 3β-Hydroxysteroid dehydrogenase deficiency: the pivotal role of gas chromatography-mass spectrometry urinary steroid metabolome analysis and a novel homozygous nonsense mutation in the
Fanis P; Neocleous V; Kosta K; Karipiadou A; Hartmann MF; Wudy SA; Karantaglis N; Papadimitriou DT; Skordis N; Tsikopoulos G; Phylactou LA; Roilides E; Papagianni M
J Pediatr Endocrinol Metab; 2021 Jan; 34(1):131-136. PubMed ID: 33180036
[TBL] [Abstract][Full Text] [Related]
38. [A novel homozygous mutation p.E25X in the HSD3B2 gene causing salt wasting 3β-hydroxysteroid dehydrogenases deficiency in a Chinese pubertal girl: a delayed diagnosis until recurrent ovary cysts].
Huang Y; Zheng J; Xie T; Xiao Q; Lu S; Li X; Cheng J; Chen L; Liu L
Zhonghua Er Ke Za Zhi; 2014 Dec; 52(12):948-51. PubMed ID: 25619355
[TBL] [Abstract][Full Text] [Related]
39. No evidence of mutations in the genes for type I and type II 3 beta-hydroxysteroid dehydrogenase (3 beta HSD) in nonclassical 3 beta HSD deficiency.
Zerah M; Rhéaume E; Mani P; Schram P; Simard J; Labrie F; New MI
J Clin Endocrinol Metab; 1994 Dec; 79(6):1811-7. PubMed ID: 7989489
[TBL] [Abstract][Full Text] [Related]
40. [Case report: congenital adrenal hyperplasia and ambiguous genitalia due to 3 beta-hydroxysteroid dehydrogenase deficiency].
Jadot O; Thiry G; Bury F
Rev Med Liege; 2004 Sep; 59(9):485-8. PubMed ID: 15559435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
